Webinar: Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

About the Webinar

Tired of working through lengthy regulatory documents? Reg Reels is a dynamic, video-led regulatory intelligence webinar designed to bring the latest pharmacovigilance regulatory developments to life.

Presented by our panel of experts, Reg Reels will showcase a curated series of short videos highlighting recent updates, guidance, regulatory decisions and emerging expectations from key health authorities. Each “reel” will provide a concise overview of what has changed, why it matters, and what it could mean for pharmacovigilance teams.

The webinar will focus on developments across major regulatory regions, including the EMA, FDA and MHRA, with topics selected for their practical impact on pharmacovigilance activities such as safety surveillance, signal management, risk management, reporting, compliance and regulatory submissions.

From recent EMA PRAC activity to new FDA guidance and emerging regulatory priorities, Reg Reels will provide a focused snapshot of the developments that pharmacovigilance professionals need to know about – without the need to sift through the source materials themselves.

Unable to join? Register and you will receive the recording after the live session.

Meet the Speakers

Angie Robertson

Senior Director, Pharmacovigilance Systems and Submissions

View Bio
Katherine (Kate) Rud

Principal Pharmacovigialnce Specialist, Systems and Submissions

View Bio
Jazmine (Jazz) Morris

Pharmacovigilance Manager, Regulatory Intelligence and Submissions

View Bio

Angie Robertson

Angie Robertson is an experienced pharmacovigilance subject matter expert with over 23 years’ experience in the pharmacovigilance space. Starting out as a nurse, then moving on to clinical research coordinator, Angie has experienced the clinical side of drug, device and vaccine safety and efficacy.

Learning end to end safety data collection and case processing led to a passion for database configuration and analytics solutions.

Angie’s practical and creative problem-solving skills have contributed to many successful safety data migrations and vendor transitions using Argus and ArisG in a pharmaceutical company setting as well as a CRO.

Katherine (Kate) Rud

Kate has over 11 years of experience in Pharmacovigilance. A Biochemist by training, Kate initially joined GSK as a clinical safety scientist, where she specialized into literature case review and processing. After moving to the USA, Kate joined the ProPharma pharmacovigilance team. In her almost 10 years with the company, Kate has covered a myriad of responsibilities, including case processing, signal detection, systems configurations and data migrations, and now regulatory intelligence. Her drive to understand and enhance systems and processes as well as close attention to quality has led to her participating in countless successful projects and initiatives over the years.

Jazmine (Jazz) Morris

Jazz is a Biomedical Scientist by training and has been working in industry (and at ProPharma) for over 11 years, firstly in Medical Information before moving into Pharmacovigilance. Starting in Medical Information has allowed her to experience the Adverse Event process from start to finish (and gave some interesting stories along the way!). Within Pharmacovigilance, Jazz has spent time doing all aspects of case processing and completing submissions of expedited and periodic reports for both clinical and post marketing clients, completing literature searches and reviews, being an LPPV and UK NCP, before moving into regulatory intelligence. Jazz now spends most of her time reviewing updates to regulations and guidance, keeping our internal Regulatory Intelligence Library up to date, as well as answering queries from colleagues and clients alike, and is lucky enough to manage arguably the best team in PV!